Peer-reviewed veterinary case report
Retinal scan findings in a dog with chronic uveodermatologic syndrome
By Gray, Alexa P et al.·Published in Veterinary ophthalmology·2026·Department of Clinical Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Features of Optical Coherence Tomography (OCT) in a Case of Chronic Uveodermatologic Syndrome.
- Species:
- dog
Plain-English summary
A 7-year-old spayed female mixed-breed dog was brought in with red eyes and suspected vision loss due to chronic uveodermatologic syndrome (UDS), which had caused eye inflammation and retinal detachments in the past. After a thorough eye exam and skin biopsies, the vet confirmed the diagnosis and started the dog on a new anti-inflammatory medication called GLS-1027 to help manage her condition. Over the next year, the dog continued to take the medication and showed no signs of eye problems during follow-up exams. This case demonstrates how advanced imaging techniques can help monitor eye health in dogs with UDS.
People also search for: dog red eyes vision loss treatment · uveodermatologic syndrome in dogs · GLS-1027 for dog eye problems
Abstract
OBJECTIVE: To report retinal optical coherence tomography (OCT) findings in a dog with chronic uveodermatologic syndrome (UDS) and to correlate these findings with clinical features to aid in diagnosis. ANIMAL STUDIED: A 7-year-old spayed female mixed-breed dog presented with red eyes and suspected vision loss. She had a history of panuveitis and bilateral bullous retinal detachments diagnosed 3 years earlier. METHODS: Complete ophthalmic examination was performed to evaluate active anterior uveitis and inactive chorioretinitis. Physical exam revealed new vitiligo and skin biopsies of the nasal planum and eyelids confirmed a diagnosis of UDS by a dermatopathologist. Fundus photography documented the retinal lesions and OCT characterized the changes to retinal structure. GLS-1027, a novel anti-inflammatory medication, was started after the most recent flare up in an attempt to control future flare ups. RESULTS: RetCam fundus photography revealed well-demarcated areas of tapetal hyperreflectivity, hyperpigmented scarring, and non-tapetal depigmentation. OCT b-scans revealed normal retinal layering in unaffected areas and marked pathologic changes in affected areas. These changes included diffuse structural alteration of the retina in areas of hyperpigmented scarring and hypopigmented regions with partial-to-complete loss of retinal thickness and structure. 12 months after the last recheck, the dog continued to receive oral GLS-1027 and had no recurrence of clinical signs on ocular exam. CONCLUSIONS: This study represented the first documentation of in vivo retinal changes in UDS using OCT imaging. This case highlighted the potential of OCT to visualize retinal changes in UDS and suggests its possible utility in disease monitoring.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/42065673/